Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-09-22

AUTHORS

Liming Wang, Xiaolan Lin, Ling Wang, Hong Ye, Yuxing Lin, Junshan Ruan, Songqing Shi

ABSTRACT

BackgroundVancomycin area under the curve/minimum inhibitory concentration (AUC/MIC) has been proposed as a therapeutic drug monitoring (TDM) target to dose vancomycin. It is time-consuming to estimate AUCs using traditional methods. A two-point trough-peak method is more straightforward for calculating the vancomycin AUC. However, the technique and the AUC/MIC target have not been validated in Chinese patients.AimTo compare the clinical outcomes of vancomycin therapy in Chinese older adults (aged > 60 years) between the trough-only and the two-point peak-trough AUC TDM approaches.MethodThe patients were divided into study and control groups according to TDM approaches. A trough-based TDM was used in the control group (target trough level 15–20 mg/L). Stanford University has provided a method to predict vancomycin AUC using peak-valley concentration alone (two-point method). A two-point trough-peak TDM approach was employed in the study group (target AUC/MIC ≥ 400). The effect of vancomycin was evaluated in terms of clinical findings, laboratory values, and bacteriologic responses. The effects of treatment and kidney functions were compared between the two groups.ResultsA total of 389 patients met the study inclusion criteria, and 189 were excluded based on the exclusion criteria. Of the 200 patients, 80 received the two-point TDM approach (the study group), and 120 were monitored using the trough-based approach (the control group). The average age was 69.8 ± 7.1 years. Staphylococcus aureus (34%) was the most common Gram-positive bacteria. No vancomycin-related nephrotoxicity was observed in either group. The percentages of patients with an excellent response to vancomycin therapy were significantly higher in the study group than in the control group, 90% (72/80) versus 73.3% (88/120), P = 0.0039.ConclusionThe two-point peak-trough method is practical for obtaining vancomycin AUC. The AUC/MIC ≥ 400 target demonstrates treatment effectiveness and safety in older Chinese patients. More... »

PAGES

1-7

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11096-022-01474-9

DOI

http://dx.doi.org/10.1007/s11096-022-01474-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1151223021

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/36136207


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Intensive Medicine, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China", 
          "id": "http://www.grid.ac/institutes/grid.415108.9", 
          "name": [
            "Department of Intensive Medicine, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Liming", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Fujian Medical University, 350001, Fuzhou, Fujian, China", 
          "id": "http://www.grid.ac/institutes/grid.256112.3", 
          "name": [
            "Medical College of Fujian Medical University, 350001, Fuzhou, Fujian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lin", 
        "givenName": "Xiaolan", 
        "id": "sg:person.014426163400.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014426163400.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China", 
          "id": "http://www.grid.ac/institutes/grid.415108.9", 
          "name": [
            "Department of Pharmacy, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Ling", 
        "id": "sg:person.010551724060.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010551724060.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China", 
          "id": "http://www.grid.ac/institutes/grid.415108.9", 
          "name": [
            "Department of Pharmacy, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ye", 
        "givenName": "Hong", 
        "id": "sg:person.07754343460.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07754343460.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China", 
          "id": "http://www.grid.ac/institutes/grid.415108.9", 
          "name": [
            "Department of Pharmacy, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lin", 
        "givenName": "Yuxing", 
        "id": "sg:person.010113433600.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010113433600.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China", 
          "id": "http://www.grid.ac/institutes/grid.415108.9", 
          "name": [
            "Department of Pharmacy, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ruan", 
        "givenName": "Junshan", 
        "id": "sg:person.016457414660.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016457414660.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Intensive Medicine, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China", 
          "id": "http://www.grid.ac/institutes/grid.415108.9", 
          "name": [
            "Department of Intensive Medicine, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shi", 
        "givenName": "Songqing", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s13318-019-00551-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1113040997", 
          "https://doi.org/10.1007/s13318-019-00551-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40266-016-0420-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042165249", 
          "https://doi.org/10.1007/s40266-016-0420-z"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-09-22", 
    "datePublishedReg": "2022-09-22", 
    "description": "BackgroundVancomycin area under the curve/minimum inhibitory concentration (AUC/MIC) has been proposed as a therapeutic drug monitoring (TDM) target to dose vancomycin. It is time-consuming to estimate AUCs using traditional methods. A two-point trough-peak method is more straightforward for calculating the vancomycin AUC. However, the technique and the AUC/MIC target have not been validated in Chinese patients.AimTo compare the clinical outcomes of vancomycin therapy in Chinese older adults (aged\u2009>\u200960\u00a0years) between the trough-only and the two-point peak-trough AUC TDM approaches.MethodThe patients were divided into study and control groups according to TDM approaches. A trough-based TDM was used in the control group (target trough level 15\u201320\u00a0mg/L). Stanford University has provided a method to predict vancomycin AUC using peak-valley concentration alone (two-point method). A two-point trough-peak TDM approach was employed in the study group (target AUC/MIC\u2009\u2265\u2009400). The effect of vancomycin was evaluated in terms of clinical findings, laboratory values, and bacteriologic responses. The effects of treatment and kidney functions were compared between the two groups.ResultsA total of 389 patients met the study inclusion criteria, and 189 were excluded based on the exclusion criteria. Of the 200 patients, 80 received the two-point TDM approach (the study group), and 120 were monitored using the trough-based approach (the control group). The average age was 69.8\u2009\u00b1\u20097.1\u00a0years. Staphylococcus aureus (34%) was the most common Gram-positive bacteria. No vancomycin-related nephrotoxicity was observed in either group. The percentages of patients with an excellent response to vancomycin therapy were significantly higher in the study group than in the control group, 90% (72/80) versus 73.3% (88/120),\u00a0P\u2009=\u20090.0039.ConclusionThe two-point peak-trough method is practical for obtaining vancomycin AUC. The AUC/MIC\u2009\u2265\u2009400 target demonstrates treatment effectiveness and safety in older Chinese patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11096-022-01474-9", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1044817", 
        "issn": [
          "2210-7703", 
          "2210-7711"
        ], 
        "name": "International Journal of Clinical Pharmacy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "vancomycin AUC", 
      "control group", 
      "vancomycin therapy", 
      "Chinese patients", 
      "study group", 
      "curve/minimum inhibitory concentration", 
      "therapeutic drug monitoring targets", 
      "AUC/MIC targets", 
      "percentage of patients", 
      "older Chinese patients", 
      "trough plasma concentrations", 
      "AUC/MIC", 
      "study inclusion criteria", 
      "common Gram-positive bacteria", 
      "effect of vancomycin", 
      "effect of treatment", 
      "Chinese older adults", 
      "dose vancomycin", 
      "MethodThe patient", 
      "bacteriologic response", 
      "MIC targets", 
      "clinical outcomes", 
      "TDM approaches", 
      "kidney function", 
      "clinical findings", 
      "ResultsA total", 
      "minimum inhibitory concentration", 
      "plasma concentrations", 
      "laboratory values", 
      "inclusion criteria", 
      "exclusion criteria", 
      "patients", 
      "average age", 
      "treatment effectiveness", 
      "clinical validation", 
      "excellent response", 
      "older adults", 
      "AUC", 
      "vancomycin", 
      "inhibitory concentration", 
      "Staphylococcus aureus", 
      "therapy", 
      "group", 
      "Gram-positive bacteria", 
      "nephrotoxicity", 
      "AimTo", 
      "target", 
      "response", 
      "adults", 
      "outcomes", 
      "age", 
      "MIC", 
      "treatment", 
      "total", 
      "criteria", 
      "aureus", 
      "concentration", 
      "safety", 
      "effect", 
      "TDM", 
      "years", 
      "findings", 
      "percentage", 
      "study", 
      "Stanford University", 
      "bacteria", 
      "function", 
      "method", 
      "effectiveness", 
      "approach", 
      "validation", 
      "area", 
      "University", 
      "values", 
      "monitoring targets", 
      "technique", 
      "two-point method", 
      "peak", 
      "terms", 
      "traditional methods", 
      "trough"
    ], 
    "name": "Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations", 
    "pagination": "1-7", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1151223021"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11096-022-01474-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "36136207"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11096-022-01474-9", 
      "https://app.dimensions.ai/details/publication/pub.1151223021"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_959.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11096-022-01474-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01474-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01474-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01474-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11096-022-01474-9'


 

This table displays all metadata directly associated to this object as RDF triples.

189 TRIPLES      21 PREDICATES      106 URIs      96 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11096-022-01474-9 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nac73c82e0e764209a5290d5806838a3d
4 schema:citation sg:pub.10.1007/s13318-019-00551-1
5 sg:pub.10.1007/s40266-016-0420-z
6 schema:datePublished 2022-09-22
7 schema:datePublishedReg 2022-09-22
8 schema:description BackgroundVancomycin area under the curve/minimum inhibitory concentration (AUC/MIC) has been proposed as a therapeutic drug monitoring (TDM) target to dose vancomycin. It is time-consuming to estimate AUCs using traditional methods. A two-point trough-peak method is more straightforward for calculating the vancomycin AUC. However, the technique and the AUC/MIC target have not been validated in Chinese patients.AimTo compare the clinical outcomes of vancomycin therapy in Chinese older adults (aged > 60 years) between the trough-only and the two-point peak-trough AUC TDM approaches.MethodThe patients were divided into study and control groups according to TDM approaches. A trough-based TDM was used in the control group (target trough level 15–20 mg/L). Stanford University has provided a method to predict vancomycin AUC using peak-valley concentration alone (two-point method). A two-point trough-peak TDM approach was employed in the study group (target AUC/MIC ≥ 400). The effect of vancomycin was evaluated in terms of clinical findings, laboratory values, and bacteriologic responses. The effects of treatment and kidney functions were compared between the two groups.ResultsA total of 389 patients met the study inclusion criteria, and 189 were excluded based on the exclusion criteria. Of the 200 patients, 80 received the two-point TDM approach (the study group), and 120 were monitored using the trough-based approach (the control group). The average age was 69.8 ± 7.1 years. Staphylococcus aureus (34%) was the most common Gram-positive bacteria. No vancomycin-related nephrotoxicity was observed in either group. The percentages of patients with an excellent response to vancomycin therapy were significantly higher in the study group than in the control group, 90% (72/80) versus 73.3% (88/120), P = 0.0039.ConclusionThe two-point peak-trough method is practical for obtaining vancomycin AUC. The AUC/MIC ≥ 400 target demonstrates treatment effectiveness and safety in older Chinese patients.
9 schema:genre article
10 schema:isAccessibleForFree false
11 schema:isPartOf sg:journal.1044817
12 schema:keywords AUC
13 AUC/MIC
14 AUC/MIC targets
15 AimTo
16 Chinese older adults
17 Chinese patients
18 Gram-positive bacteria
19 MIC
20 MIC targets
21 MethodThe patient
22 ResultsA total
23 Stanford University
24 Staphylococcus aureus
25 TDM
26 TDM approaches
27 University
28 adults
29 age
30 approach
31 area
32 aureus
33 average age
34 bacteria
35 bacteriologic response
36 clinical findings
37 clinical outcomes
38 clinical validation
39 common Gram-positive bacteria
40 concentration
41 control group
42 criteria
43 curve/minimum inhibitory concentration
44 dose vancomycin
45 effect
46 effect of treatment
47 effect of vancomycin
48 effectiveness
49 excellent response
50 exclusion criteria
51 findings
52 function
53 group
54 inclusion criteria
55 inhibitory concentration
56 kidney function
57 laboratory values
58 method
59 minimum inhibitory concentration
60 monitoring targets
61 nephrotoxicity
62 older Chinese patients
63 older adults
64 outcomes
65 patients
66 peak
67 percentage
68 percentage of patients
69 plasma concentrations
70 response
71 safety
72 study
73 study group
74 study inclusion criteria
75 target
76 technique
77 terms
78 therapeutic drug monitoring targets
79 therapy
80 total
81 traditional methods
82 treatment
83 treatment effectiveness
84 trough
85 trough plasma concentrations
86 two-point method
87 validation
88 values
89 vancomycin
90 vancomycin AUC
91 vancomycin therapy
92 years
93 schema:name Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations
94 schema:pagination 1-7
95 schema:productId Na0c4db6316354dbfb1ba498079019fe8
96 Na8cb1c03c52b4220b35caa2bf4f43f52
97 Naae0f024a4b442afa4ed29d04129ced7
98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1151223021
99 https://doi.org/10.1007/s11096-022-01474-9
100 schema:sdDatePublished 2022-12-01T06:44
101 schema:sdLicense https://scigraph.springernature.com/explorer/license/
102 schema:sdPublisher Nd0c2016ef965441a9abda38a8ea91a26
103 schema:url https://doi.org/10.1007/s11096-022-01474-9
104 sgo:license sg:explorer/license/
105 sgo:sdDataset articles
106 rdf:type schema:ScholarlyArticle
107 N1233d109c1d24b658c764f77c792f2ea schema:affiliation grid-institutes:grid.415108.9
108 schema:familyName Shi
109 schema:givenName Songqing
110 rdf:type schema:Person
111 N2626120f79414effa5cff209194d459c rdf:first N1233d109c1d24b658c764f77c792f2ea
112 rdf:rest rdf:nil
113 N3c5b52e3e2cc46dd863c5d52b77c7c30 rdf:first sg:person.07754343460.01
114 rdf:rest N67caf6e9ceef40b6a339d0d8c204bfd2
115 N67caf6e9ceef40b6a339d0d8c204bfd2 rdf:first sg:person.010113433600.49
116 rdf:rest Nd44d0f0841374e1588b29f0dca900e9e
117 N7455675db35641f19ff70a2aec5354da rdf:first sg:person.010551724060.80
118 rdf:rest N3c5b52e3e2cc46dd863c5d52b77c7c30
119 Na0c4db6316354dbfb1ba498079019fe8 schema:name doi
120 schema:value 10.1007/s11096-022-01474-9
121 rdf:type schema:PropertyValue
122 Na8cb1c03c52b4220b35caa2bf4f43f52 schema:name pubmed_id
123 schema:value 36136207
124 rdf:type schema:PropertyValue
125 Naae0f024a4b442afa4ed29d04129ced7 schema:name dimensions_id
126 schema:value pub.1151223021
127 rdf:type schema:PropertyValue
128 Nac73c82e0e764209a5290d5806838a3d rdf:first Nbd1c95eecf184c8b94884bee4b4eb82c
129 rdf:rest Ne9fbbe255f5b45a58839dba62b1b3ba7
130 Nbd1c95eecf184c8b94884bee4b4eb82c schema:affiliation grid-institutes:grid.415108.9
131 schema:familyName Wang
132 schema:givenName Liming
133 rdf:type schema:Person
134 Nd0c2016ef965441a9abda38a8ea91a26 schema:name Springer Nature - SN SciGraph project
135 rdf:type schema:Organization
136 Nd44d0f0841374e1588b29f0dca900e9e rdf:first sg:person.016457414660.23
137 rdf:rest N2626120f79414effa5cff209194d459c
138 Ne9fbbe255f5b45a58839dba62b1b3ba7 rdf:first sg:person.014426163400.26
139 rdf:rest N7455675db35641f19ff70a2aec5354da
140 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
141 schema:name Medical and Health Sciences
142 rdf:type schema:DefinedTerm
143 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
144 schema:name Clinical Sciences
145 rdf:type schema:DefinedTerm
146 sg:journal.1044817 schema:issn 2210-7703
147 2210-7711
148 schema:name International Journal of Clinical Pharmacy
149 schema:publisher Springer Nature
150 rdf:type schema:Periodical
151 sg:person.010113433600.49 schema:affiliation grid-institutes:grid.415108.9
152 schema:familyName Lin
153 schema:givenName Yuxing
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010113433600.49
155 rdf:type schema:Person
156 sg:person.010551724060.80 schema:affiliation grid-institutes:grid.415108.9
157 schema:familyName Wang
158 schema:givenName Ling
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010551724060.80
160 rdf:type schema:Person
161 sg:person.014426163400.26 schema:affiliation grid-institutes:grid.256112.3
162 schema:familyName Lin
163 schema:givenName Xiaolan
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014426163400.26
165 rdf:type schema:Person
166 sg:person.016457414660.23 schema:affiliation grid-institutes:grid.415108.9
167 schema:familyName Ruan
168 schema:givenName Junshan
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016457414660.23
170 rdf:type schema:Person
171 sg:person.07754343460.01 schema:affiliation grid-institutes:grid.415108.9
172 schema:familyName Ye
173 schema:givenName Hong
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07754343460.01
175 rdf:type schema:Person
176 sg:pub.10.1007/s13318-019-00551-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113040997
177 https://doi.org/10.1007/s13318-019-00551-1
178 rdf:type schema:CreativeWork
179 sg:pub.10.1007/s40266-016-0420-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1042165249
180 https://doi.org/10.1007/s40266-016-0420-z
181 rdf:type schema:CreativeWork
182 grid-institutes:grid.256112.3 schema:alternateName Medical College of Fujian Medical University, 350001, Fuzhou, Fujian, China
183 schema:name Medical College of Fujian Medical University, 350001, Fuzhou, Fujian, China
184 rdf:type schema:Organization
185 grid-institutes:grid.415108.9 schema:alternateName Department of Intensive Medicine, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China
186 Department of Pharmacy, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China
187 schema:name Department of Intensive Medicine, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China
188 Department of Pharmacy, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, No. 134 Dongjie Road, 350001, Fuzhou, Fujian, China
189 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...